Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): A single-arm, two-stage, open-label, multi-centre, phase II clinical trial protocol. (2017)

First Author: Arndtz K

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2016-015081

PubMed Identifier: 28674140

Publication URI: http://europepmc.org/abstract/MED/28674140

Type: Journal Article/Review

Volume: 7

Parent Publication: BMJ open

Issue: 6

ISSN: 2044-6055